Company: INGN
Filing Date: 2025-02-28
Form Type: 10-K
Source: 0000950170-25-029993
Chunk: 214

Company: Inogen Inc
Filing Date: 2025-02-28
Form: 10-K
Item: Item 1A
Chunk 214
---
. If an active trading market does not develop, you may have difficulty selling any of our shares of common stock that you buy. In addition, the trading price of our common stock may be highly volatile. During the last twelve months, our common stock traded as high as $13.33 per share and as low as $5.08 per share. The trading price of our common stock could continue to be subject to wide fluctuations in price in response to various factors, some of which are beyond our control. These factors include: 

•actual or anticipated quarterly variation in our results of operations or the results of our competitors; 

•announcements of secondary offerings;

•announcements by us or our competitors of new commercial products, significant contracts, commercial relationships, or capital commitments; 

•issuance of new or changed securities analysts’ reports or recommendations for our stock; 

•developments or disputes concerning our intellectual property or other proprietary rights; 

•commencement of, or our involvement in, litigation; 

•market conditions in the oxygen therapy market; 

•reimbursement or legislative changes in the oxygen therapy market; 

•failure to complete significant sales; 

•manufacturing disruptions that could occur if we were unable to successfully expand our production in our current or an alternative facility or due to any other reason; 

•any future sales of our common stock or other securities; 

•any major change to the composition of our board of directors or management;

•announcements by us or our competitors of significant acquisitions, strategic partnerships, joint ventures, or capital commitments;

•the other factors described in this “Risk Factors” section; and 

•general economic conditions and slow or negative growth of our markets.

The stock market in general and market prices for the securities of technology-based companies like ours in particular, have from time-to-time experienced volatility that often has been unrelated to the operating performance of the underlying companies. These broad market and industry fluctuations may adversely affect the market price of our common stock, regardless of our operating performance. 

 53

Price volatility over a given period or a low stock price could result in a number of negative outcomes, including, but not limited to:

•creating potential limitations on the ability to raise capital through the issuance of equity or equity linked securities;

•impacting the value of our equity compensation, which affects our ability to recruit and retain employees;

•impairing goodwill or long-lived assets;

•difficulty complying with the listing standards of Nasdaq; and

•increasing the risk of regulatory proceedings